These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1550 related articles for article (PubMed ID: 8652275)

  • 21. B7 and interleukin 12 cooperate for proliferation and interferon gamma production by mouse T helper clones that are unresponsive to B7 costimulation.
    Murphy EE; Terres G; Macatonia SE; Hsieh CS; Mattson J; Lanier L; Wysocka M; Trinchieri G; Murphy K; O'Garra A
    J Exp Med; 1994 Jul; 180(1):223-31. PubMed ID: 7516409
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Allogeneic lymphocyte responses to B7-1 expressing human cancer cell lines.
    Dessureault S; Gallinger S
    J Surg Res; 1996 Jul; 64(1):42-8. PubMed ID: 8806472
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human hepatoma cells expressing MHC antigens display accessory cell function: dependence on LFA-1/ICAM-1 interaction.
    Paroli M; Carloni G; Franco A; De Petrillo G; Alfani E; Perrone A; Barnaba V
    Immunology; 1994 Jun; 82(2):215-21. PubMed ID: 7927492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inflammatory cells infiltrating human colorectal carcinomas express HLA class II but not B7-1 and B7-2 costimulatory molecules of the T-cell activation.
    Chaux P; Moutet M; Faivre J; Martin F; Martin M
    Lab Invest; 1996 May; 74(5):975-83. PubMed ID: 8642792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FcR cross-linking on monocytes results in impaired T cell stimulatory capacity.
    Barcy S; Wettendorff M; Leo O; Urbain J; Kruger M; Ceuppens JL; de Boer M
    Int Immunol; 1995 Feb; 7(2):179-89. PubMed ID: 7537534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of T cell autoreactivity to MHC class II by controlling CD80 (B7-1) expression on B cells.
    Hasegawa A; Ueno Y; Yamashita M; Nakayama T; Tada T
    Int Immunol; 1998 Feb; 10(2):147-58. PubMed ID: 9533442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Successful adoptive immunotherapy of murine poorly immunogenic tumor with specific effector cells generated from gene-modified tumor-primed lymph node cells.
    Tanaka H; Yoshizawa H; Yamaguchi Y; Ito K; Kagamu H; Suzuki E; Gejyo F; Hamada H; Arakawa M
    J Immunol; 1999 Mar; 162(6):3574-82. PubMed ID: 10092816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of cytokines and CD80 for enhancement of immunogenicity of cervical cancer cells.
    Kaufmann AM; Gissmann L; Simms P; Schreckenberger C; Qiao L
    Immunobiology; 2000 Nov; 202(4):339-52. PubMed ID: 11131151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antigenicity of human melanoma cells transfected to express the B7-1 co-stimulatory molecule (CD80) varies with the level of B7-1 expression.
    McCarthy DO; Glowacki N; Schell K; Emler CA; Albertini MR
    Cancer Immunol Immunother; 2000 May; 49(2):85-93. PubMed ID: 10823418
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential modulation of immune recognition molecules by interleukin-7 in human acute leukaemias.
    Costello RT; Mallet F; Chambost H; Sainty D; Gastaut JA; Olive D
    Eur Cytokine Netw; 1999 Mar; 10(1):87-96. PubMed ID: 10210778
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An intra-Peyer's patch gene transfer model for studying mucosal tolerance: distinct roles of B7 and IL-12 in mucosal T cell tolerance.
    Chen Y; Song K; Eck SL
    J Immunol; 2000 Sep; 165(6):3145-53. PubMed ID: 10975828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of interferon-gamma and tumour necrosis factor-alpha on the development of cytotoxic T lymphocytes in autologous mixed lymphocyte tumour cultures with human melanoma.
    Roth AD; Hornicek FJ; Gerstner CG; Kirkwood JM
    Clin Exp Immunol; 1991 Oct; 86(1):163-72. PubMed ID: 1833098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of CD80 expression by fibroblast-like synoviocytes leading to anergy in T lymphocytes.
    Corrigall VM; Solau-Gervais E; Panayi GS
    Arthritis Rheum; 2000 Jul; 43(7):1606-15. PubMed ID: 10902766
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antigen presentation by interferon-gamma-treated thyroid follicular cells inhibits interleukin-2 (IL-2) and supports IL-4 production by B7-dependent human T cells.
    Lombardi G; Arnold K; Uren J; Marelli-Berg F; Hargreaves R; Imami N; Weetman A; Lechler R
    Eur J Immunol; 1997 Jan; 27(1):62-71. PubMed ID: 9021999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alloantigen-specific T-cell anergy induced by human keratinocytes is abrogated upon loss of cell-cell contact.
    Otten HG; Bor B; Ververs C; Verdonck LF; De Boer M; De Gast GC
    Immunology; 1996 Jun; 88(2):214-9. PubMed ID: 8690453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recombinant adeno-associated virus (rAAV) vector-mediated cotransduction of CD70 and CD80 into human malignant melanoma cells results in an additive T-cell response.
    Braun-Falco M; Hallek M
    Arch Dermatol Res; 2001 Feb; 293(1-2):12-7. PubMed ID: 11289576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apoptotic cell death in conjunction with CD80 costimulation confers uveal melanoma cells with the ability to induce immune responses.
    Carlring J; Shaif-Muthana M; Sisley K; Rennie IG; Murray AK
    Immunology; 2003 May; 109(1):41-8. PubMed ID: 12709016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. B7.1 gene transduction of human renal-cell-carcinoma cell lines restores the proliferative response and cytotoxic function of allogeneic T cells.
    Bain C; Merrouche Y; Puisieux I; Duc A; Colombo MP; Favrot M
    Int J Cancer; 1996 Sep; 67(6):769-76. PubMed ID: 8824547
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of HLA-A2 antigen in human melanoma cell lines and its role in T-cell recognition.
    Pandolfi F; Boyle LA; Trentin L; Kurnick JT; Isselbacher KJ; Gattoni-Celli S
    Cancer Res; 1991 Jun; 51(12):3164-70. PubMed ID: 1904004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation of tumor-specific CTLs from melanoma patients by using peripheral blood stimulated with allogeneic melanoma tumor cell lines. Fine specificity and MART-1 melanoma antigen recognition.
    Stevens EJ; Jacknin L; Robbins PF; Kawakami Y; el Gamil M; Rosenberg SA; Yannelli JR
    J Immunol; 1995 Jan; 154(2):762-71. PubMed ID: 7814882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 78.